Published
Phillip J. Koo, MD analyzes therapeutic radiopharmaceuticals and their evolving role in the management of prostate cancer.
#urology #urologist #prostatecancer #oncology #radiopharmaceutical
#urology #urologist #prostatecancer #oncology #radiopharmaceutical
- Categoria
- Urology
Commenta per primo questo video.
Prossimo
-
15:57
IFC CNR radiopharmaceuticals facility: an opportunity for regional and national cancer patients
-
18:24
Decipher Prostate | A Urologist’s Personal Decipher Prostate Journey
-
06:46
KRT17: Unlocking Cancer Therapy Resistance and Emerging Therapeutic Strategies
-
04:13
Hold and Kill” Therapeutic Fast Tracked for Metastatic Castration-Resistant Prostate Cancer
-
08:49
KRT17: A Key Driver of Cancer Therapy Resistance and Emerging Therapeutic Target
-
19:09
Prostate Cancer Awareness Month: The Urologist and Oncologist Perspectives
-
12:46
Evolving Role of Bone Health and Radiopharmaceuticals in Prostate Cancer Care
-
12:46
Evolving Role of Bone Health and Radiopharmaceuticals in Prostate Cancer Care
-
10:01
KRT17: Unlocking Cancer Therapy Resistance and Emerging Therapeutic Strategies
-
06:24
A Urologist answers: Does prostate massage have any health benefits?
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
